Fate Therapeutics Inc. (NASDAQ:FATE)

There are currently no videos for this stock.
To request coverage of this stock, please click the green request video box on the right.
Bands Volume 200 SMA 50 SMA 20 SMA Videos Alerts Articles Events
FATE Weekly Chart

Old Forum Content for FATE

Make a Forum Post
Become a member to view recent forum posts. Already a member? Sign in here.
Loading...
  • captron: $FATE - Started a small spec position here. There is a lot written about this biotech company. 2 or 3 drugs in the pipeline for next year.
  • WebstreamDyn: $FATE - another bio with a big jump today
  • debeers: $FATE-Clues you can use. Bought this am here's why:
    1.The look at last month- Healthcare in the US was down 1.65%, healthcare in the world down 1.08%, S&P healthcare down .47%. $FATE was UP-3.21%
    2. I NEVER ever look at thinly traded stocks. If ...
  • petros06: @debeers $FATE Thx for sharing your thought process. It's helpful
  • debeers: @petros06 $FATE -you are welcome. PS Boeing will come out of this mr. petros. PS---remember to not leave trash anywhere near the tanker site. Thanks
  • JeffyJ: $FATE looks as though some of you guys hopped on
  • CHOFF: $FATE - continuing the breakout with a 10% push today
  • CHOFF: $FATE - finally breaking out. We'll see if it sticks or rolls over. #CAR-T #CRISPR
  • CHOFF: $FATE - posted a while ago on this one. Aggressive buying happening in it the last two days. Resistance at 14.45.
  • Sher: @CHOFF $FATE - Interesting company name...
  • CHOFF: $FATE - up 14.6% and a big jump in volume today...its NK100 drug showed early signs of efficacy in two patients with ovarian cancer, prompting a price-target upgrade from Wedbush.The company, which now has a $19 price target and an outperform rating, said its Phase 1 Apollo data of NK100 showed the drug was effective. Other Biotechs getting hammered as a group after a strong morning run.
  • steve71: @CHOFF $FATE IMHO, a 14% jump based on a 2 patient P1 trial is a SELL. 2 Patients... When I was in med school we had a "friendly" rivalry with Johns Hopkins. One dig was that a Hopkins series of 12 meant 1 patient examined by 12 physicians.
  • CHOFF: $CRSP $FATE - added these two Bios to my growth portfolio. I found these via my Minervini Scan. They've been at the top of my scan results for several days. $CRSP reports tomorrow. $FATE reported on the 5th, dropped, and has since resumed trend. Both are up 7%+ today. Keep in mind, they are biotechs...
  • CHOFF: @woodman $EDIT $CRSP - just posted on $CRSP and then saw your post below. I too have been watching this one intently. Who knows what happens tomorrow when it reports other then it will be losing money like all the bios. It might follow $FATE 's pattern with a drop and them a trend resumption.
  • captron: $FATE - I like the way this chart is shaping up. Anyone ever trade it. Don't see many post on it. It came up on one of my Minervini scans.
  • shoredriver: @captron $FATE Earnings Monday....
  • mradams0621: ...
    $FATE Fate Therapeutics... 3.85 8.45%
    $CERC Cerecor Inc 3.39 7.96%
    $RCMT Rcm Technologies ... 5.00 7.76%
    $SQM Sociedad Quimica ... 17.02 7.18%
    $CDXS Codexis Inc. 4.50 7.14%
    $GLF Gulfmark Offshore... 5.03 6.34%
    $SBGL Sibanye Gold Ltd ... 5.89 ...
  • judysteiner: $FATE--enters i n deal with JUNO
Visit the Trading Forum to join in the discussion.
Stock Price $USD 32.43
Change 0.65%
Volume 850,914

Fate Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the development of programmed cellular therapeutics for the treatment of severe, life-threatening diseases.

Request Video of FATE
Already a member? Sign in here.

Earnings

  • August 6th, 2020 - 2020 Q2 Earnings
Past Month

Leading Peers

Past Month

Lagging Peers

Dan Fitzpatrick

Stock Market Mentor gives you EVERYTHING you need to succeed in the market; all in one place. How easy is that? Dan Fitzpatrick and his elite community of traders share trading ideas, strategies and much more. Dan Fitzpatrick--a world class Technical Analyst, trading coach and regular CNBC contributor--gives you access to all of this with a 30 day trial membership for just $7.77. Get started TODAY and start trading better TOMORROW with the following premium content:

  • Nightly video Strategy Sessions with a game plan for tomorrow
  • Got a stock you want Dan to look at? Just ask.
  • Patent pending video alerts instantly delivered to you when one of Dan’s trading signals is triggered. This is not your typical price alert. This is a short video explaining the action you need to take to make money. No more “Woulda, coulda, shoulda”
  • Access to over 70,900 stock analysis videos
  • Access an ever expanding library (70,900) of educational videos that will save you time and make you money

Join a team of friends and traders that have one thing in common; a burning desire to succeed.

Become a Member Today!

Gain immediate access to all our exclusive articles, features, how-to's, discussion group and much more...

Satisfaction Guaranteed!

Your Stock Market Mentor membership comes with a 30 day, no questions asked, 100% money back guarantee!